Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals. by Schmidt, B, Tameris, M, Geldenhuys, H, Luabeya, A, Bunyasi, E, Hawkridge, T, McClain, J, Mahomed, H, Scriba, T, McShane, H, Hatherill, M

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hanekom, W, Mahomed, H, McShane, H

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study by Andrews, J, Nemes, E, Tameris, M, Landry, B, Mahomed, H, McClain, J, Fletcher, H, Hanekom, W, Wood, R, McShane, H, Scriba, T, Hatherill, M

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. by Gale, N, Thurston, G, Hackett, S, Renard, R, Wang, Q, McClain, J, Martin, C, Witte, C, Witte, M, Jackson, D, Suri, C, Campochiaro, P, Wiegand, S, Yancopoulos, G

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hussey, G, Hanekom, W, Mahomed, H, Mahomed, H, McShane, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, van der Merwe, L, de Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, Van Der Merwe, L, De Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants. by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H

T-cell activation is an immune correlate of risk in BCG vaccinated infants by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H